Evidence map›Paper›PMID 35977948›Full record

ArticleCell death & disease2022

Dominant-negative p53-overexpression in skeletal muscle induces cell death and fiber atrophy in rats.

Henning T Langer, Agata A Mossakowski, Rasheed Sule, Aldrin Gomes, Keith Baar

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The proteasome regulates body weight and systemic nutrient metabolism during fasting.American journal of physiology. Endocrinology and metabolism · 2023
    Article
  9. Article
  10. Role of p53 in Cisplatin-Induced Myotube Atrophy.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Henning T Langer *Department of Physiology and Membrane Biology, University of California, Davis, CA, USA. htlanger@ucdavis.edu.ORCID 0000-0003-1838-4279
Agata A Mossakowski *Neurobiology, Physiology and Behavior, University of California, Davis, CA, USA.
Rasheed SuleNeurobiology, Physiology and Behavior, University of California, Davis, CA, USA.ORCID 0000-0001-9759-0809
Aldrin GomesDepartment of Physiology and Membrane Biology, University of California, Davis, CA, USA.ORCID 0000-0002-9819-3036
Keith BaarDepartment of Physiology and Membrane Biology, University of California, Davis, CA, USA.
University of California, Davis · USCornell University · USHumboldt-Universität zu Berlin · DEVA Northern California Health Care System · US

Funding

TRANSLOCATION OF p66Shc: KINETICS, FUNCTION, APOPTOSISP01AG025532 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KIM, KYOUNGMI · 2007 to 2017
$12.1M
Role of the Extracellular Matrix in Age-Associated Strength Loss: Combining Imaging and Biochemistry to create a Multi-Scale Mesh-free ModelR01AG056999 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SINHA, SHANTANU · 2018 to 2022
$3.1M
LAT1 and the development of anabolic resistanceR01AG045375 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BAAR, KEITH · 2014 to 2018
$1.7M
NIA NIH HHS P01 AG025532NIA NIH HHS R01 AG045375NIA NIH HHS R01 AG056999
6 · The paper itself

Abstract

The tumor suppressor p53 is thought to play a key role in the maintenance of cell size and homeostasis, but relatively little is known about its role in skeletal muscle. Based on its ability to suppress cell growth, we hypothesized that inhibiting the function of wild-type p53 through the overexpression of a dominant-negative p53 mutant (DDp53) could result in muscle fiber hypertrophy. To test this hypothesis, we electroporated adult rat tibialis anterior muscles with DDp53 and collected the tissue three weeks later. We confirmed successful overexpression of DDp53 on a histological and biochemical level and found pronounced changes to muscle architecture, metabolism, and molecular signaling. Muscle mass, fiber cross-sectional area, and fiber diameter significantly decreased with DDp53 overexpression. We found histopathological changes in DDp53 transfected muscle which were accompanied by increased levels of proteins that are associated with membrane damage and repair. In addition, DDp53 decreased oxidative phosphorylation complex I and V protein levels, and despite its negative effects on muscle mass and fiber size, caused an increase in muscle protein synthesis as assessed via the SUnSET technique. Interestingly, the increase in muscle protein synthesis was concomitant with a decrease in phospho-S6K1 (Thr389). Furthermore, the muscle wasting in the DDp53 electroporated leg was accompanied by a decrease in global protein ubiquitination and an increase in proteasome activity. In conclusion, overexpression of a dominant-negative p53 mutant in skeletal muscle results in decreased muscle mass, myofiber size, histological muscle damage, a metabolic phenotype, and perturbed homeostasis between muscle protein synthesis and degradation.

Indexed as

Muscle, SkeletalTumor Suppressor Protein p53AnimalsAtrophyCell DeathMuscle Fibers, SkeletalMuscle ProteinsMuscular AtrophyRatsMuscle ProteinsTumor Suppressor Protein p53

Identifiers

PMID35977948
PMCPMC9385859
OpenAlexW4292133550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.